Skip to Content

NATCO 3 mg (Budesonide (Enteric Coated) 3 mg)

Pill with imprint NATCO 3 mg is Gray & Pink, Capsule-shape and has been identified as Budesonide (Enteric Coated) 3 mg. It is supplied by Alvogen, Inc..

Budesonide is used in the treatment of crohn's disease; asthma, maintenance; crohn's disease, acute; inflammatory bowel disease; crohn's disease, maintenance and belongs to the drug classes glucocorticoids, inhaled corticosteroids. Risk cannot be ruled out during pregnancy. Budesonide 3 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NATCO 3 mg

Budesonide (Enteric Coated)

Imprint
NATCO 3 mg
Strength
3 mg
Color
Gray & Pink
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Glucocorticoids, Inhaled corticosteroids
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Alvogen, Inc.
National Drug Code (NDC)
47781-0146
Inactive Ingredients
acetyltributyl citrate, cetyl alcohol, ethylcelluloses, ferric oxide red, ferrosoferric oxide, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polysorbate 80, sodium lauryl sulfate, corn starch, sucrose, magnesium silicate, titanium dioxide, triethyl citrate, water, gelatin, potassium hydroxide, propylene glycol, ammonia, shellac

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.